Diplomat Pharmacy is stabilizing after being heavily oversold and below MAs. A bounce from this area would allow for 10% targets around $22 per share based off price structure.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
